New-Onset Seizures Linked to COVID-19 Show Good Prognosis

Source: Frontiers in neurology

Summary

This study looked at patients who started having seizures for the first time during a COVID-19 infection. Researchers focused on 34 patients, dividing them into two groups: one group had severe brain issues (Group 1) and the other did not (Group 2). The study took place at a single center from December 2022 to June 2023, and it included both men and women, with ages ranging from younger adults to older individuals.

The findings showed that patients in Group 1, who had more severe brain problems, experienced seizures much sooner after their COVID-19 diagnosis compared to those in Group 2. Group 1 also had a higher rate of a serious type of seizure called status epilepticus. Interestingly, while Group 1 showed some brain activity changes on EEG tests, Group 2 had more signs of epilepsy on their tests. In the end, more patients in Group 2 were diagnosed with epilepsy than those in Group 1.

These results are important because they suggest that new seizures related to COVID-19 generally have a good outlook, with fewer patients developing drug-resistant epilepsy. However, the study has limitations, such as being conducted at a single center and involving a small number of patients, which means the findings may not apply to everyone. More research is needed to understand the long-term effects of COVID-19 on seizures and epilepsy.

Original source